{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:03:08Z","timestamp":1785225788497,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.redox.2026.104296","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:14:15Z","timestamp":1783919655000},"page":"104296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeted degradation of hepatic KEAP1 mitigates drug-induced liver injury via dual boosting NRF2 and PGAM5 signaling"],"prefix":"10.1016","volume":"95","author":[{"given":"Yanyan","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leizhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7013-8013","authenticated-orcid":false,"given":"Zhiyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangping","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6159-2626","authenticated-orcid":false,"given":"Lili","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9670-4349","authenticated-orcid":false,"given":"Guangbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2026.104296_bib1","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001281","article-title":"Assessment of liver injury potential of investigational medicines in drug development","author":"Chalasani","year":"2025","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.redox.2026.104296_bib2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2023.02.034","article-title":"The exposome and liver disease - how environmental factors affect liver health","volume":"79","author":"Barouki","year":"2023","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.redox.2026.104296_bib3","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1016\/j.jhep.2024.10.030","article-title":"Real-world evidence supporting the consensus-driven DILI control compounds list: an analysis of FAERS data","volume":"82","author":"Ge","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.redox.2026.104296_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155142","article-title":"Drug-induced liver injury and anti-hepatotoxic effect of herbal compounds: a metabolic mechanism perspective","volume":"122","author":"Rani","year":"2024","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.redox.2026.104296_bib5","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jhep.2021.06.021","article-title":"Advanced preclinical models for evaluation of drug-induced liver injury - consensus statement by the European Drug-induced liver injury network [PRO-EURO-DILI-NET]","volume":"75","author":"Fernandez-Checa","year":"2021","journal-title":"J. Hepatol."},{"issue":"20","key":"10.1016\/j.redox.2026.104296_bib6","doi-asserted-by":"crossref","first-page":"11397","DOI":"10.1021\/acs.jmedchem.0c00524","article-title":"Mechanisms and medicinal chemistry avoidance\/mitigation strategies","volume":"63","author":"Norman","year":"2020","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.redox.2026.104296_bib7","doi-asserted-by":"crossref","first-page":"6949","DOI":"10.1007\/s11033-021-06674-6","article-title":"Mitochondrial stress response in drug-induced liver injury","volume":"48","author":"Zheng","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.redox.2026.104296_bib8","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1053\/j.gastro.2016.12.016","article-title":"Association of Liver injury from specific drugs, or groups of drugs, with polymorphisms in HLA and other genes in a genome-wide association study","volume":"152","author":"Nicoletti","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.redox.2026.104296_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/17562848231163410","article-title":"Drug-induced liver injury: a comprehensive review","volume":"16","author":"Hosack","year":"2023","journal-title":"Therap Adv Gastroenterol"},{"issue":"1","key":"10.1016\/j.redox.2026.104296_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"10.1016\/j.redox.2026.104296_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70044","article-title":"Small extracellular vesicles engineered using click chemistry to express chimeric antigen receptors show enhanced efficacy in acute liver failure","volume":"14","author":"Lu","year":"2025","journal-title":"J. Extracell. Vesicles"},{"issue":"1","key":"10.1016\/j.redox.2026.104296_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41392-024-02095-6","article-title":"Redox regulation: mechanisms, biology and therapeutic targets in diseases","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"7","key":"10.1016\/j.redox.2026.104296_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.redox.2026.104296_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.tips.2013.01.009","article-title":"Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria","volume":"34","author":"Han","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.redox.2026.104296_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103593","article-title":"Keap1-independent Nrf2 regulation: a novel therapeutic target for treating kidney disease","volume":"82","author":"Zhang","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104296_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102389","article-title":"Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway","volume":"54","author":"Liu","year":"2022","journal-title":"Redox Biol."},{"issue":"38","key":"10.1016\/j.redox.2026.104296_bib17","article-title":"Ponicidin promotes hepatocellular carcinoma mitochondrial apoptosis by stabilizing Keap1-PGAM5 complex","volume":"11","author":"Zhao","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.redox.2026.104296_bib18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/jacs.9b06528","article-title":"Photoproximity profiling of protein-protein interactions in cells","volume":"142","author":"McCutcheon","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.redox.2026.104296_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102186","article-title":"A novel role of KEAP1\/PGAM5 complex: ROS sensor for inducing mitophagy","volume":"48","author":"Zeb","year":"2021","journal-title":"Redox Biol."},{"issue":"20","key":"10.1016\/j.redox.2026.104296_bib20","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1242\/jcs.203216","article-title":"A PGAM5-KEAP1-Nrf2 complex is required for stress-induced mitochondrial retrograde trafficking","volume":"130","author":"O'Mealey","year":"2017","journal-title":"J. Cell Sci."},{"issue":"8","key":"10.1016\/j.redox.2026.104296_bib21","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.yexcr.2008.02.014","article-title":"PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria","volume":"314","author":"Lo","year":"2008","journal-title":"Exp. Cell Res."},{"issue":"8","key":"10.1016\/j.redox.2026.104296_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112895","article-title":"PGAM5 is an MFN2 phosphatase that plays an essential role in the regulation of mitochondrial dynamics","volume":"42","author":"Nag","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.redox.2026.104296_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101771","article-title":"Songorine promotes cardiac mitochondrial biogenesis via Nrf2 induction during sepsis","volume":"38","author":"Li","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104296_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102624","article-title":"Contribution of NRF2 to sulfur metabolism and mitochondrial activity","volume":"60","author":"Alam","year":"2023","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.redox.2026.104296_bib25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41590-017-0013-y","article-title":"Oxeiptosis, a ROS-induced caspase-independent apoptosis-like cell-death pathway","volume":"19","author":"Holze","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.redox.2026.104296_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.redox.2016.12.022","article-title":"The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2\/PINK1","volume":"11","author":"Xiao","year":"2017","journal-title":"Redox Biol."},{"issue":"11","key":"10.1016\/j.redox.2026.104296_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142438","article-title":"NRF2 regulates PINK1 expression under oxidative stress conditions","volume":"10","author":"Murata","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.redox.2026.104296_bib28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.redox.2026.104296_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/med.21925","article-title":"KEAP1-NRF2 protein-protein interaction inhibitors: design, pharmacological properties and therapeutic potential","volume":"43","author":"Crisman","year":"2023","journal-title":"Med. Res. Rev."},{"issue":"4","key":"10.1016\/j.redox.2026.104296_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.apsb.2015.05.008","article-title":"Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents","volume":"5","author":"Abed","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"8","key":"10.1016\/j.redox.2026.104296_bib31","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.chembiol.2020.07.020","article-title":"PROTACs: an emerging therapeutic modality in precision medicine","volume":"27","author":"Nalawansha","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.redox.2026.104296_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ddtec.2019.01.002","article-title":"PROteolysis TArgeting Chimeras (PROTACs) - past, present and future","volume":"31","author":"Pettersson","year":"2019","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.redox.2026.104296_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102783","article-title":"Development of KEAP1-targeting PROTAC and its antioxidant properties: in vitro and in vivo","volume":"64","author":"Park","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104296_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2025.05.025","article-title":"Chemical knockdown of Keap1 and homoPROTAC-ing allergic rhinitis","author":"Yan","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"14","key":"10.1016\/j.redox.2026.104296_bib35","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1039\/D2CS00200K","article-title":"Target and tissue selectivity of PROTAC degraders","volume":"51","author":"Guenette","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"2","key":"10.1016\/j.redox.2026.104296_bib36","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41557-023-01379-8","article-title":"Proteolysis-targeting chimeras with reduced off-targets","volume":"16","author":"Nguyen","year":"2024","journal-title":"Nat. Chem."},{"issue":"13","key":"10.1016\/j.redox.2026.104296_bib37","doi-asserted-by":"crossref","first-page":"9184","DOI":"10.1021\/acs.jmedchem.3c00822","article-title":"Discovery of NAFLD-improving agents by promoting the degradation of Keap1","volume":"66","author":"Qi","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.redox.2026.104296_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102552","article-title":"Design and characterization of a heterobifunctional degrader of KEAP1","volume":"59","author":"Chen","year":"2023","journal-title":"Redox Biol."},{"issue":"7","key":"10.1016\/j.redox.2026.104296_bib39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41568-025-00817-8","article-title":"Targeted protein degradation for cancer therapy","volume":"25","author":"Hinterndorfer","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.redox.2026.104296_bib40","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.chembiol.2022.08.004","article-title":"Target protein localization and its impact on PROTAC-mediated degradation","volume":"29","author":"Simpson","year":"2022","journal-title":"Cell Chem. Biol."},{"issue":"1","key":"10.1016\/j.redox.2026.104296_bib41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.28251","article-title":"Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells","volume":"63","author":"Sun","year":"2016","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.redox.2026.104296_bib42","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41419-019-1880-y","article-title":"Effect of early-stage autophagy inhibition in BRAF(V600E) autophagy-dependent brain tumor cells","volume":"10","author":"Zahedi","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2026.104296_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103737","article-title":"Discovery of a novel chalcone-derived covalent Keap1 binder for mitigating cisplatin-induced mitochondrial dysfunction and nephrotoxicity","volume":"85","author":"Deng","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104296_bib44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.redox.2015.01.005","article-title":"Mechanisms of cell death pathway activation following drug-induced inhibition of mitochondrial complex I","volume":"4","author":"Imaizumi","year":"2015","journal-title":"Redox Biol."},{"issue":"12","key":"10.1016\/j.redox.2026.104296_bib45","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1080\/15548627.2024.2384348","article-title":"Preserving mitochondrial homeostasis protects against drug-induced liver injury via inducing OPTN (Optineurin)-dependent mitophagy","volume":"20","author":"Wang","year":"2024","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.redox.2026.104296_bib46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41591-024-03434-4","article-title":"Artificial intelligence in drug development","volume":"31","author":"Zhang","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.redox.2026.104296_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155458","article-title":"Xanthohumol ameliorates drug-induced hepatic ferroptosis via activating Nrf2\/xCT\/GPX4 signaling pathway","volume":"126","author":"Deng","year":"2024","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.redox.2026.104296_bib48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/brainsci13010145","article-title":"The neuroprotective effects and therapeutic potential of the chalcone cardamonin for alzheimer's disease","volume":"13","author":"Barber","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.redox.2026.104296_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.108109","article-title":"Design, synthesis, and biological evaluation of novel FGFR1 PROTACs","volume":"155","author":"Wang","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.redox.2026.104296_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107613","article-title":"Novel PROTAC probes targeting FOSL1 degradation to eliminate head and neck squamous cell carcinoma cancer stem cells","volume":"151","author":"Zaman","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"16","key":"10.1016\/j.redox.2026.104296_bib51","article-title":"Gasdermin-E-Dependent non-canonical pyroptosis promotes drug-induced liver failure by promoting CPS1 deISGylation and degradation","volume":"11","author":"Ouyang","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"4","key":"10.1016\/j.redox.2026.104296_bib52","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16167","article-title":"Novel emerging mechanisms in Acetaminophen (APAP) hepatotoxicity","volume":"45","author":"Hionides-Gutierrez","year":"2025","journal-title":"Liver Int."},{"issue":"1738","key":"10.1016\/j.redox.2026.104296_bib53","first-page":"373","article-title":"DNAJ proteins in neurodegeneration: essential and protective factors","author":"Zarouchlioti","year":"2018","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726002958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726002958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:51:32Z","timestamp":1785225092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231726002958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":53,"alternative-id":["S2213231726002958"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2026.104296","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted degradation of hepatic KEAP1 mitigates drug-induced liver injury via dual boosting NRF2 and PGAM5 signaling","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2026.104296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104296"}}